期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

核因子-κB与肝癌发展关系的研究进展 被引量：6

原文传递
导出
摘要 NF-κB与肝癌的发生发展密切相关，了解NF-κB与细胞、基因之间的调节作用能为肝癌的治疗提供新的策略和途径。
作者 张平平 汪培钦 陈岳祥
机构地区 上海长征医院消化内科
出处 《中华消化杂志》 CAS CSCD 北大核心 2014年第1期65-67,共3页 Chinese Journal of Digestion
关键词 核因子-ΚB 肝癌 NF-ΚB
分类号 R735.7 [医药卫生—肿瘤]
  • 相关文献

参考文献26

  • 1Kataoka T. Chemical biology of inflammatory cytokine signaling[J].{H}Journal of Antibiotics(Tokyo),2009,(12):655-667.
  • 2Karin M,Greten FR. NF-kappaB:linking inflammation and immunity to cancer development and progression[J].{H}Nature reviews Immunology,2005,(10):749-759.
  • 3Chua HL,Bhat-Nakshatri P,Clare SE. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells:potential involvement of ZEB1 and ZEB-2[J].{H}ONCOGENE,2007,(5):711-724.
  • 4Lian S,Meng L,Liu C. PRL-3 activates NF-κB signaling pathway by interacting with RAP1[J].{H}Biochemical and Biophysical Research Communications,2013,(1):196-201.
  • 5Yokouchi Y,Vogan KJ,Pearse RV 2nd. Antagonistic signaling by Caronte,a novel Cerberus-related gene,establishes left-right asymmetric gene expression[J].{H}CELL,1999,(5):573583.
  • 6Sun J,Yeung CA,Co NN. Clitocine reversal of P-glycoprotein associated multi-drug resistance through down regulation of transcription factor NF-κB in R-HepG2 cell line[J].PLoSOne,2012,(8):e40720.
  • 7Liu Q,Chen J,Liu L. The X protein of hepatitis B virus inhibits apoptosis in hepatoma cells through enhancing the methionine adenosyltransferase 2A gene expression and reducing S-adenosylmethionine production[J].{H}Journal of Biological Chemistry,2011,(19):17168-17180.
  • 8Clippinger AJ,Bouchard MJ. Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential[J].{H}Journal of Virology,2008,(14):6798-6811.
  • 9Choi SH,Park KJ,Ahn BY. Hepatitis C virus nonstructural 5B protein regulates tumor necrosis factor alpha signaling through effects on cellular IkappaB kinase[J].{H}Molecular and Cellular Biology,2006,(8):3048-3059.
  • 10Lee TH,Tai DI,Cheng CJ. Enhanced nuclear factor kappa B-associated Wnt-1 expression in hepatitis B-and Crelated hepatocarcinogenesis:identification by functional proteomics[J].{H}JOURNAL OF BIOMEDICAL SCIENCE,2006,(1):27-39.

二级参考文献21

  • 1张必翔,陈孝平,张万广,余红平,朱虹,罗顺峰,王其,吴在德,裘法祖.核转录因子-κB对肝癌细胞Hep3B COX-2表达的调节[J].中华实验外科杂志,2004,21(7):824-825. 被引量：2
  • 2Drisko JA, Chapman J, Hunter VJ. The use of antioxidant therapies during chemotherapy [ J]. Gynecol Oncol, 2003, 88 (3) :434-439.
  • 3Wang J, Huang Q, Chen M. The role of NF-kappa B in hepatocellular carci a cell [J]. Chin Med J(Engl), 2003, 116(5) :747- 752.
  • 4Um JH, Kang CD, Lee BG, et al. Increased and correlated nuclear factor- kappa B and Ku autoantigen activities are associated with development of multidrug resistance [ J ] . Oncogene, 2001, 20 ( 42 ) :6048-6056.
  • 5Monks NR, Biswas DK, Pardee AB. Blocking anti-apoptosis as a strategy for eaneer chemotherapy : NF-kappaB as a target [ J ]. J Cell Bioehem, 2004, 92(4) :646-650.
  • 6Castells A, Balaguer F, Gonzalo V, Castellvi-Bel S. Cyclooxygenase 2 and colorectal cancer: therapeutic implications. Gastroenterol Hepatol.2007; 30:280-284.
  • 7Chi-Man Tang T, Tung-Ping Poon R, Fan ST. The significance of cyclooxygenase-2 expression in human hepatocellular carcinoma. Biomed Pharmacother 2005; 59 Suppl 2:S311-S316.
  • 8Amir M, Agarwal HK. Role of COX-2 selective inhibitors for prevention and treatment of cancer. Pharmazie 2005; 60:563-570.
  • 9Schonthal AH. Direct non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapy. Br J Cancer 2007; 97:1465-1468.
  • 10Grosch S, Maier TJ, Schiffmann S, Geisslinger G. Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst 2006; 98:736-747.

共引文献13

同被引文献53

  • 1朱医高,逄越,李庆伟.肿瘤坏死因子受体超家族成员在免疫系统和疾病中的研究[J].中国生物化学与分子生物学报,2020,36(2):141-151. 被引量：11
  • 2Conrado M Fernández-Rodríguez,María Luisa Gutiérrez-García.Prevention of hepatocellular carcinoma in patients with chronic hepatitis B[J].World Journal of Gastrointestinal Pharmacology and Therapeutics,2014,5(3):175-182. 被引量：9
  • 3赵弘智,梁平,李靖,李洪艳,黄小兵.肝癌相关cDNA片段的快速克隆和表达[J].世界华人消化杂志,2004,12(8):1785-1788. 被引量：8
  • 4赵弘智,李靖,梁平,李洪艳,黄小兵.一条肝癌相关新基因的全长cDNA克隆[J].中华肝脏病杂志,2005,13(7):483-483. 被引量：7
  • 5Besson A,Dowdy S F,Roberts J M. CDK inhibitors:ce11 cycle regula- tors and beyond[ J]. Dev Cell,2008,14 : 159-169.
  • 6Broude E V,Swift M E,Vivo C,et al. p21 ( Wafl/Cipl/Sdil ) medi- ates retinoblastoma protein degradation [ J ]. Oncogene, 2007,26 : 6954-6958.
  • 7Cioca A, Cimpean A, Ceausu R, et al. Crosstalk between EGFR and P53 in hepatoeellular carcinoma [ J ]. Asian Pae J Cancer Prey,2014, 15 ( 19 ) :8069-8073.
  • 8Duronio R J, Xiong Y. Signaling pathways that control cell prolifera- tion[J]. Cold Spring Harb Perspect Bio1,20!3,5 :a008904.
  • 9Mirzayans R, Andrais B, Scott A, et al. New insights into p53 signa- ling and cancer cell response to DNA damage:implications for cancer therapy[ J ]. J Biomed Biotechno1,2012 : 170325.
  • 10Rayess H, Wang M B, Srivatsan E S. Cellular senescence and tumor suppressor gene pl 6 [ J ]. International journal of cancer, 2012,130 : 1715-1725.

引证文献6

二级引证文献21

中华消化杂志
2014年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部